Upmc serves as Executive at Evolent Health, Inc., where they oversee executive responsibilities. Since joining the company, Upmc has executed 7 insider transactions totaling $178.8M, demonstrating a bearish approach to their equity position. Their most recent transaction on May 4, 2021 involved exercising options for 823,945 shares valued at $0.
Upmc currently holds 823,945 shares of Evolent Health, Inc. (EVH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Upmc has been a net seller of EVH stock. They have purchased $0 and sold $178.8M worth of shares.
Upmc's most recent insider trade was on May 4, 2021, when they sold 823,945 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| May 19, 2017 | EVH | $56.7M | Sale | 2,333,333 | $24.30 | Discretionary |
| May 1, 2017 | EVH | $7.9M | Sale | 403,644 | $19.53 | Discretionary |
| Mar 31, 2017 | EVH | $52.6M | Sale | 2,690,961 | $19.53 | Discretionary |
| Sep 22, 2016 | EVH | $8.7M | Sale | 403,644 | $21.54 | Discretionary |
| Sep 14, 2016 | EVH | $53.0M | Sale | 2,460,307 | $21.54 | Discretionary |